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Akt signalingProprotein convertases (PCs) formagroupof serine endoproteases that are essential for the activationof proproteins
into their active form. Some PCs have been proposed to be potential therapeutic targets for cancer intervention be-
cause elevated PC activity has been observed inmany different cancer types and becausemany of the PC substrates,
such as pro-IGF-1R, pro-TGF-beta, pro-VEGF, are involved in signaling pathways related to tumor development.
Curcumin, reported to possess anticancer activity, also affects many of these pathways. We therefore investigated
the effect of curcumin on PC activity. Our results show that curcumin inhibits PC activity in a cell lysate-based
assay but not in vitro. PC zymogen maturation in the endoplasmic reticulum appears to be inhibited by curcumin.
Treating cells with thapsigargin or cyclopiazonic acid, two structurally unrelated inhibitors of the sarco- and endo-
plasmic reticulum Ca2+ATPase (SERCA), also hampered both the PC zymogen maturation and the PC activity. Im-
portantly, curcumin, like the SERCA inhibitors, impaired ATP-driven 45Ca2+ uptake in the endoplasmic reticulum.
These results indicate that curcumin likely restrains PC activity by inhibiting SERCA-mediated Ca2+-uptake activity.
Experiments in three colon cancer cell lines conﬁrm that curcumin inhibits both the 45Ca2+ uptake and PC activity,
notably the processing of pro-IGF-1R. Both curcumin and thapsigargin inhibit the anchorage-independent growth of
these three colon carcinoma cell lines. In conclusion, our ﬁndings indicate that curcumin inhibits PC zymogen mat-
uration and consequently PC activity and that its inhibitory effect on Ca2+ uptake into the ER allows and is sufﬁcient
to explain this phenomenon.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Proprotein convertases (PCs) form a family of seven closely related
subtilisin-like serine endoproteases. The family members include furin,
PC1/3, PC2, PC4, PC5/6, PACE4 and PC7 [1]. The proprotein convertases,-4-methyl coumarin; Akt1, v-akt
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l rights reserved.depending of their compartments of action, have different optima for
pH and calcium (Ca2+) concentration. The post-translational pro-
cessing of their inactive precursor molecules – zymogens – through
endoproteolytic cleavage, is a prerequisite for the formation of bio-
logically active proprotein convertases. There are also differences in
pH optima and Ca2+ requirements for these maturation processes [2,3].
PCs cleave and thereby activate a large variety of proproteins, such as
growth factors, receptors, enzymes and cell adhesionmolecules. As a con-
sequence these enzymesplay important roles inmaintaining homeostasis
[4].
Furin and its family members have similar substrate speciﬁcities and
preferentially cleave C-terminally of paired basic amino acids. Knockout
mousemodels have been generated to investigate the roles of PCs in var-
ious pathologies [5] and the possible redundancies of various PCs [6].
Embryos lacking furin die in the second week of pregnancy. They show
multiple tissue abnormalities including severe ventral closure defects
and the failure of the heart tube to fuse and undergo loopingmorphogen-
esis [7]. In contrast to the indispensable role of furin during embryogene-
sis, its function in adult life appears to be partially redundant, as shownby
conditional furin inactivation in mice in speciﬁc organs [8–12].
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Firstly, the expression of some PCs is increased in several cancer types,
such as breast, non-small-cell lung cancers and head and neck cancers
[13]. Moreover, for some PCs, for instance furin, expression and tumor
aggressiveness are highly correlated [13,14]. A number of PC substrates,
once processed, are involved in various signaling pathways which play
very essential roles in tumor development. Examples are: transforming
growth factor beta (TGF-beta) [15], vascular endothelial growth factor
(VEGF) [16], glypicans (GPCs) [17], insulin-like growth factor 1 and its
receptor (IGF-1 and IGF-1R) [18,19].
Curcumin, a polyphenol and a main component of the Indian spice
turmeric, has been reported to possess anti-cancer effect in several cancer
types [20]. Curcumin affects several signaling pathways in which PC sub-
strates are playing an important role. In fact the signaling by most of the
matured forms of the PC substrates mentioned above, as e.g. TGF-beta
[21,22], VEGF [23,24] and IGF-1R [25], is also inﬂuenced by curcumin.
For this reason it seemed opportune to investigate whether curcumin
had impact on PC activity and therefore on downstream targets in differ-
ent signaling pathways.
While fully aware that such potential PC modulating activity would
have impact on many pathways, we focused our study on the impact of
curcumin on IGF-1R processing in the context of a potential anti-cancer
effect in the intestine.
Curcumin has been shown to inhibit the IGF-1 signaling pathway in
breast carcinoma cells [26]. In colon cancer cells both pro-IGF-1 and
pro-IGF-1R are processed by PCs [18,19]. It has been shown to have
chemopreventive activity in a mouse model of familial adenomatous
polyposis (FAP) [27]. Moreover, curcumin showed some efﬁcacy in a
small clinical trial of FAP chemoprevention [28]. Aberrant crypt foci
(ACF), clusters of abnormal tube-like glands in the lining of the colon
and rectum have been claimed to represent the earliest histologically
identiﬁable changes in the colon of patients with FAP [29]. A recent
Phase IIa clinical trial of curcumin for the prevention of colorectal neopla-
sia showed a signiﬁcant reduction in the number of ACF at a daily dose of
4 g of curcumin [30]. With respect to the neoplastic progression of colo-
rectal polyps towards cancer, a signiﬁcant correlation between the ex-
pression of the IGF-1R and neoplastic progression from normal mucosa
to adenomatous polyps and ﬁnally to colorectal cancer has been demon-
strated [31]. In light of the latter, IGF-1R is being considered as a promis-
ing therapeutic target in colorectal cancer [32].
As a consequence, it is plausible that curcumin could act on the level of
the IGF-1Rwhich is synthesized as a proprotein that needs PC activity for
its activation.We therefore investigatedwhether curcumin acted as an in-
hibitor of pro-IGF-1R processing because such an inhibitory activity could
also explain its action on several other signaling pathways. Furthermore,
we have investigated the molecular basis of curcumin-induced PC
inhibition.
2. Materials and methods
2.1. Materials and cell lines
A puriﬁed, biologically active, soluble, recombinant human furin frag-
ment prepared as previously described [33] was used for in vitro enzyme
assays. This human furin fragment was isolated from CHO-K1 cells stably
transfectedwith aDNAconstruct expressing a truncatedhumanpro-furin
fragment consisting of amino acids 1–573. This pro-furin fragment is
processed into a soluble, enzymatically active furin fragment, which con-
sists of amino acids 108–573 and has been designated hfurin573 in this
manuscript.
Curcumin was obtained from Sigma-Aldrich and a 10 mM stock so-
lution for use in experiments was made in ethanol. Thapsigargin (TG)
and cyclopiazonic acid (CPA) were purchased from Sigma-Aldrich and
1 mM stock solutions were prepared in ethanol and dimethylsulfoxide
(DMSO), respectively. As ﬂuorogenic peptide substrate Pyr-RTKR-AMC
(Pyr = pyroglutamic acid, AMC = 7-Amino-4-methylcoumarin) wasused (Bachem). Uncleaved pro-diphtheria toxin was obtained from
Merck and the proprotein convertase inhibitor nona-D-arginine (D9R)
from Pepscan, Prestio.
Cell lines included CHO (ATCC CCL-61), RPE.40 [34], HT-29 (ATCC
CCL-218), SW480 (ATCC CCL-228) and Caco-2 (ATCC HTB-37).
2.2. Cell culture and incubation of cells with curcumin, TG or CPA
RPE.40, CHO, HT-29, SW480 and Caco-2 cells were grown in DMEM/
F12 (1:1) (Invitrogen™) supplemented with 10% fetal calf serum
(Hyclone) and cultured at 37 °C in a humidiﬁed 5% CO2 atmosphere.
For in vitro experiments, a stock solution of 10 mMcurcumin (prepared
in ethanol) was diluted with cell culture medium to obtain concentra-
tions of 2–20 μM curcumin for cell treatments. Cells were treated with
curcumin for 24 h. In experiments with transfected cells, cells were
after transfection ﬁrst grown in culturemediumwithout curcumin dur-
ing 24 h and, subsequently, the cells were cultured for 24 h in medium
containing various concentrations of curcumin. During curcumin appli-
cation, light exposure was reduced as much as possible. In control exper-
iments, the effect of 0.2% ethanol was monitored which is the highest
concentration of the solvent used. In experiments with the SERCA inhibi-
tors TGor CPA, cellswere treated according to a similar protocol as used in
experiments with curcumin.
2.3. DNA constructs and transfection
To test the effect of curcumin on the processing of pro-protein sub-
strates by endogenous PCs in cells, full length cDNA encoding pro-IGF-
1R, HA-tagged pro-GPC3, or HA-tagged pro-GPC4, which constitute
established PC substrates, were transfected into CHO cells or cells of the
furin-deﬁcient cell line RPE.40. Full length human IGF-IR cDNA (hIGF-IR)
(kind gift of Dr. Kooijman, VUB, Belgium; [35]), full length human GPC3
cDNA (kind gift of Dr. G. David; [36]) or full length human GPC4 cDNA
(kind gift of Dr. G. David; [36]) in the pcDNA3 expression vector were
used. In similar cotransfection experiments, the effect of curcumin onpro-
cessing of the afore-mentioned proproteins by exogenously expressed
human furin, PC5/6 or PC7 was studied in RPE.40 cells. Furthermore, to
test the effect of curcuminon thematuration of PCs, expression constructs
encoding human furin, PC1/3 or PC7 were transfected into CHO cells. For
all constructs expressing one of thesemembers of themammalian family
of PCs, expression vector pcDNA3 was used. For expression of wild-type
human furin, the 4.1 EcoR1 FUR cDNA [37] was used. Human PC1/3 was
expressed as a FLAG-tagged PC1/3 fusionprotein [38] andexpression con-
structs for human PC5/6 [39] and PC7 [40] have been described before.
Expression of a human PC1/3 mutant construct encoding pro-PC1/3mut,
which contains an inactivating mutation in the middle domain (G593R)
causing ER retention of its pro-form [38], was used in control experi-
ments. Transfections were performed using FugeneTM 6 Transfection
Reagent (Roche) according to the manufacturer's protocol. About 24 h
after transfection, the PC zymogens, the proprotein substrates and their
corresponding processing products were studied by Western blotting
analysis using speciﬁc antibodies. Similar experimental conditions as
used to study the effects of curcumin on pro-furin maturation were se-
lected to evaluate the effects of TG or CPA on the maturation of pro-
furin as well as the effects of curcumin and TG on the maturation of
pro-PC1/3 and pro-PC7.
2.4. Western blotting analysis
Cells were lysed about 24 h after transfection in SDS-PAGE sam-
ple buffer (50 mM Tris–HCl, pH 6.8, 10% glycerol, 2% SDS, and 4%
β-mercaptoethanol) and after boiling of the solution for 10 min,
samples were loaded on a 10% SDS-polyacrylamide gel. After separa-
tion on the basis of molecular weight, proteins were transferred elec-
trophoretically onto Protran® nitrocellulose transfer membranes
(Whatmann GmbH) and subjected to Western blotting analysis.
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bit anti-hIGF-1R α-subunit antibody (SC-712; Santa Cruz). Expres-
sion of the HA-tagged GPC3 and GPC4 proteins was evaluated with a
mouse anti-HA tag monoclonal antibody (monoclonal antibody 16B12,
Covance). Expression of the pro- and mature forms of human furin was
detected usingmonoclonal antibodyMON-148 (ENZO), which speciﬁcal-
ly recognizes the subtilisin-like catalytic domain of furin [41]. The identity
of pro-furin was conﬁrmed with a home-made rabbit polyclonal antise-
rum raised against the pro-domain of human pro-furin (designated
hPro-furinAb). Human PC1/3 was expressed as FLAG-tagged PC1/3 and
could be detected by anti-FLAGM2 antibody (Sigma-Aldrich). Expression
of PC7 was detected with anti-PC7 antibody KP1 [42]. Expression of the
Akt and its phosphorylated form pAkt was evaluated using, respectively,
rabbit anti-Akt antibody Akt(pan) and the Phospho-Akt (Thr308) anti-
body, that recognizes only the phosphorylated form of Akt (Cell Signaling
Technology). As a control, the expression level of actin was evaluated
using an anti-β-actin monoclonal antibody from Sigma-Aldrich.
2.5. In vitro processing of uncleaved diphtheria toxin by hfurin573
Puriﬁed hfurin573was preincubatedwith 5 μMD9Ror different con-
centrations of curcumin (5, 10, 15, or 20 μM) in Hepes I buffer (100 mM
Hepes, 0.5% Triton X-100, 0.5 mM CaCl2) at room temperature for
30 min. After the preincubation, 3 μg of the uncleaved diphtheria
toxin (ﬁnal concentration 0.3 μg/μl) was added and the mixture
was incubated at 37 °C for an hour. The ﬁnal concentration of hfurin573
was 0.03 ng/μl. Processing of the diphtheria toxin pro-protein into the A-
and B-fragments was evaluated by SDS polyacrylamide gel electrophore-
sis analysis and proteins were visualized by Coomassie blue staining
(Merck Chemicals).
2.6. Determination of endogenous PC activity
The procedure for measuring the endogenous PC activity was as fol-
lows: CHO, HT-29, Caco-2 or SW480 cells were grown till conﬂuence
and treated in each experiment for 24 h with different concentrations
of curcumin, TG or CPA, as indicated in the ﬁgures. Cells were washed
twice with PBS buffer and then lysed in 100 μl TNT buffer (10 mM
Tris–HCl (pH 7.2), 0.15 M NaCl, 0.1% Triton X-100, and protease inhib-
itor mix (1.0 μM E-64, 0.1 μM leupeptin, 1.0 μM pepstatin, 0.01 mM
TPCK). The cell lysate was centrifuged in a minifuge at 13,000 rpm for
one minute. The supernatant was transferred to another tube and the
protein concentration was measured using a BCA (bicinchonic acid)
protein assay kit (Thermo Scientiﬁc) according to the manufacturer's
protocol. Each sample was adjusted by TNT buffer to achieve the same
protein concentration. In order to measure the PC activity, 25 μl of cell
lysate was added to each well of 96-well microtiter plates, then 20 μl
Hepes II buffer (250 mM Hepes (pH 7.0), 0.25% Triton X-100, 12.5 mM
CaCl2, and the above-mentioned protease inhibitor mix) was added be-
fore the addition of the ﬂuorogenic peptide substrate Pyr-RTKR-AMC
(200 μM ﬁnal concentration) and incubation at 37 °C was continued.
25 μl cell lysate for each curcumin concentration plus 25 μl Hepes buffer
II (pH 7.0) were used as controls. Fluorescence was measured at 37 °C
at 5-minute intervals for one hour. An excitation wavelength of 390 nm
and an emission wavelength of 460 nmwere used. The relative PC activ-
ity, after incubation of one hour, was plotted against the concentrations of
curcumin, TGor CPA. Determination of PC processing activity in themedi-
um was performed similarly.
2.7. Monitoring the effects of curcumin, TG and CPA on maturation of the
PC zymogens, pro-furin, pro-PC1/3, and pro-PC7
To investigate the possible inﬂuence of curcumin, TG and CPA on
pro-furinmaturation, CHO cells were transfectedwith an expression con-
struct encoding full length human pro-furin. 24 h after transfection with
the pro-furin encoding DNA, various concentrations of curcumin, TG orCPAwere added to the culture medium. After 12 h of incubation, the cul-
turemediumwas removed and cellswerewashed twicewithDMEM/F12
medium and cultured overnight in serum-free medium containing the
different compounds. Subsequently, culture medium was removed and
half of the medium was processed for PC activity measurement; the
other half was precipitated using four volumes of methanol and the pres-
ence of FUR gene-encoded proteins in the medium was visualized by
SDS-PAGE and Western blotting analysis. The cells were lysed in 200 μl
of TNT buffer, as described above. Half of the lysate was used further for
PC activity analysis and the other half was used to determine the FUR
gene-encoded proteins in the cell lysate by SDS-PAGE andWestern blot-
ting analysis using the antibodies mentioned above.
2.8. Real-time quantitative reverse transcription polymerase chain
reaction (qRT-PCR)
Total RNA was extracted from cells by using the Nucleospin RNA II
kit according to the manufacturer's instructions. 1 μg of total RNA was
reverse transcribed into cDNA using random hexamer primers and su-
perscript III reverse transcriptase (Invitrogen™) according to themanu-
facturer's guidelines. cDNA was diluted 10 times for analysis. Real
time qRT-PCR was performed using the mastermix for SYBR green I
detection and ﬂuorescein as internal standard (Eurogentec). 40 cy-
cles of annealing/extension for 1 min at 60 °C were carried out
with the MylQ system (Bio-Rad). Primer sequences for analyzing ex-
pression of GAPDH, which is used as reference gene, are: forward primer,
5′-CCCATCACCATCTTCCAGGA-3′; reverse primer, 5′-CTTCTCCATGGTGG
TGAAGAC-3′ [43]. Primer sequences for analyzing expression of IGF-1R:
forward primer, 5′-AGGGGAATTTCATCCCAAAT-3′; reverse primer, 5′-G
AGCAGGATGTGGAGGTAGC-3′. Primers were designed with primer ex-
press software (Applied Biosystems). The primer sequences for analyzing
expression of the human FUR, PACE4, PC5/6, and PC7 genes have been de-
scribed previously and included: for the PC5/6 gene: forward primer,
5′-ATCCCTGCCAGTCTGACATGA-3′; reverse primer, 5′-TTCTCCAGCACAG
CGAGTC-3′ [44]; for the PACE4 gene: forward primer, 5′-GCCAAACCTG
TGTAGGCATT-3′; reverse primer, 5′-CTGGGTTCTCTCCAGCTCAC-3′ [44];
for the PC7 gene: forward primer, 5′-GCACCCAACTATAGCCCTGA-3′; re-
verse primer, 5′-TCCATGCTGTCTGTGAGAGG-3′ [45]; for the FUR gene:
forward primer, 5′-ACAACTATGGGACGCTGACC-3′; reverse primer, 5′-T
GGACACAGCTCTTCTGGTG-3′ [44]. All RNA samples were evaluated by
real time qRT-PCR in triplicate reactions and every experiment was re-
peated three times. The relative amounts of mRNA expressionwere cal-
culated by using the mathematical model for relative quantiﬁcation in
real-time qRT-PCR [46] with normalization relative to GAPDH mRNA
levels.
2.9. Experimental conditions to determine unidirectional 45Ca2+ ﬂuxes
CHO, HT-29 and SW480 cells were plated at 50 × 103 cells/well in
gelatin-coated 12-well plates (Costar, MA) and grown for 7 days until
conﬂuent monolayers were formed. The 12-well plates were ﬁxed on a
thermostated plate at 25 °C on amechanical shaker. 45Ca2+ unidirection-
al ﬂux experiments were performed after saponin treatment, essentially
as previously described [47]. The culture medium was aspirated, and
the cells were permeabilized by incubating them for 10 min in a solution
containing 120 mM KCl, 30 mM imidazole–HCl (pH 6.8), 2 mM MgCl2,
1 mM ATP, 1 mM EGTA and 20 μg/ml saponin. The non-mitochondrial
Ca2+ storeswere then loaded for 45 min in 120 mMKCl, 30 mM imidaz-
ole–HCl (pH 6.8), 5 mMMgCl2, 5 mMATP, 0.44 mMEGTA, 10 mMNaN3
and150 nM free 45Ca2+ (28 μCi/ml). During the loading phase, cellswere
exposed to curcumin at a concentration ranging from 2 to 20 μMor to TG
(1 μM), as indicated. Subsequently, cells were twice washedwith 1 ml
of efﬂux medium containing 120 mM KCl, 30 mM imidazole–HCl
(pH 6.8) and 1 mM EGTA supplemented with 4 μM TG to remove
non-speciﬁcally bound 45Ca2+. After this procedure, efﬂux medium
(2 ml) was added and replaced every 2 min during 10 min. At the end
Fig. 2. Evaluation of PC-mediated processing of proproteins in furin-deﬁcient RPE.40 cells. A: Pro-protein pro-IGF-1R was expressed in RPE.40 cells upon transfection of a corresponding DNA
expression construct, as described inMaterials andmethods. Pro-IGF-1R is not processed by endogenous PCs in RPE.40 cells (upper panel) or by exogenous PC7 expressed upon transfection of a
PC7DNAexpression construct (lower panel). Pro-IGF-1R is readily processed by the co-expressed proprotein convertases furin or PC5/6, as visualized by the appearance of theα-chain process-
ing product and such processing is inhibited by curcumin, as shown in the two middle panels. Expression levels of actin are shown as protein loading control. B: Pro-protein pro-GPC3 was
expressed in RPE.40 cells upon transfection of a corresponding DNA expression construct, as described in Materials and methods. Pro-GPC3 is processed by endogenous PCs in RPE.40 cells
as can be deduced by the presence of mature GPC3. Curcumin is shown to inhibit the pro-GPC3 processing by endogenous PCs expressed in RPE.40 cells (upper panel). A similar result was
obtained for the processing of pro-GPC4 and for its inhibition by curcumin (lower panel). Expression levels of actin are shown as protein loading control.
Fig. 1. Features of curcumin interferencewith proprotein convertase-mediated processing. A: Chemical structure of the polyphenolic compound curcumin and relative endogenous PC activity
in CHO cell lysates after treatment of cellswith the polyphenolic compounds (−)EGC, biochanin A, curcumin, or chrysin at the concentrations indicated in the ﬁgure. Treatment of the CHO cells
and preparation of the cell lysates were performed as described in Materials and methods. PC-mediated cleavage was assayed in vitro using the ﬂuorogenic peptide substrate Pyr-RTKR-AMC.
Data represent mean ± SEM of 3 independent experiments, each performed in triplicate. B: SDS-PAGE analysis of the effect of curcumin on the hfurin573-mediated in vitro processing of
uncleaved diphtheria toxin into the A- and B-fragment. Molecular weight markers (lane 1); hfurin573-mediated processing in control conditions (lane 2); or in the presence of 5 μM D9R
(lane 3); 5 μM curcumin (lane 4); 10 μM curcumin (lane 5); 15 μM curcumin (lane 6); and 20 μM curcumin (lane 7). C: Inhibitory effect of curcumin on the processing of proproteins in
CHO cells. CHO cells were transfected with expression constructs encoding pro-IGF-1R, pro-GPC3, or pro-GPC4 and cultured in the presence of various concentrations of curcumin (Cur), as
indicated. Expression levels of the various proproteins and their corresponding processing products, produced via endogenous PC-mediated processing, are visualized viawestern blotting anal-
ysis as described in Materials and methods. Expression levels of actin are shown as protein loading control.
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incubation with 1 ml of a 2% sodium dodecyl sulfate (SDS) solution
for 30 min. The 45Ca2+ content in the ER at the start of the efﬂux
(0 min) was calculated by summing in retrograde order the SDS-releasable 45Ca2+ and the 45Ca2+ released during the efﬂux period
while subtracting for each time point the TG-resistant 45Ca2+ uptake
[48,49]. Concentration–response curves were ﬁtted using OriginPro 8
SR0 (OriginLab Corporation; Northampton, MA) software using the
1929J. Zhu et al. / Biochimica et Biophysica Acta 1833 (2013) 1924–1935Hill equation. The dose-response curves represent the mean ± SEM of
3 to 5 independent experiments, each performed in duplicate. To deter-
mine the effect of curcumin on the unidirectional Ca2+-leak from the
ER, different curcumin concentrations ranging from 5 to 30 μM were
added during the efﬂux phase during the indicated time period (6 min).
The Ca2+-ionophore A23187 was used as a positive control. The data
were plotted as normalized 45Ca2+ content as a function of time.
2.10. Cell viability/proliferation assay
Cell viability/proliferation upon treatment with curcumin or TG was
studied using the colon carcinoma cell lines HT-29, Caco-2, and SW480.
Cells were detached by trypsinization, seeded at 5000 cells/48-well mi-
crotiter plate and cultured for 24 h. Then they were treated with varying
concentrations of curcumin or TG, and incubated for an additional 48 h.
The effect of curcumin or TG on cell growth was examined by the 3-
(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell
viability/proliferation assay. Brieﬂy, 100 μl of MTT solution (5 mg/ml;
Sigma-Aldrich) was added to each well and incubated for 4 h at 37 °C.
The supernatant was aspirated, and the MTT formazan that was formed
by metabolically viable cells was dissolved in 150 μl of DMSO, and then
monitored by a Dynatech MR5000 microplate reader (Dynatech Corp.,
Burlington, MA) at a wavelength of 590 nm. The data are expressed as
the percentage viable cells as compared with the number of cells in the
control (taken as 100%), as determined by the MTT reduction test.
2.11. Colony formation in soft agar
The impact of the treatment of cells with curcumin or TG on colony
formation of cells of the colon carcinoma cell lines HT-29, SW480 and
Caco-2 was investigated as follows. Cells (10,000 cells/well) were seed-
ed onto wells of 6-well plates in culture medium (supplemented with
50 ng/ml IGF-1) containing 0.35% low-melting agarose (FMC Corp.,
Rockland, ME) over a 0.7% agarose layer in the presence of varying con-
centrations of curcumin, TG or control vehicle, as indicated, and incubat-
ed for 3 weeks at 37 °C. Fresh medium (supplemented with 30 ng/ml
IGF-1) containing the appropriate concentration of curcumin or TG was
added and refreshed every other day during the 3-week period. Colony
formation in soft agar was monitored using an Axiovert 200 M inverted
microscope (Zeiss) and scored 3 weeks after seeding of the cells. The im-
pact of the protein-based inhibitor 1-antitrypsin Portland (α1-PDX) on
colony formation by HT-29, SW480 and Caco-2 cells was investigated inFig. 3. Effect of various concentrations of curcumin, TG or CPA on zymogenmaturation of pro-prot
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ence of increasing concentrations of curcumin, as indicated in theﬁgure, detectable levels ofmature
4). Inhibition of pro-PC1/3maturation by various concentrations of the SERCA Ca2+ pump inhibito
of curcumin (upper panel) or TG (lower panel) on zymogen maturation of pro-PC2 expressed in C
blotting analysis, as described in Materials and methods. Concentrations of added compounds are
pro-PC2 (75 kDa) andmature PC2 (64 kDa) could be observed in CHO cell lysates (lane 1 in upper
panel) or TG (lanes 2–3, lower panel), the ratio between mature PC2 and pro-PC2 decreased. F: E
maturation of pro-PC7 expressed in CHO cells upon transfection of a corresponding expression con
centrations of added compounds are indicated in the ﬁgure. In the absence of curcumin (upper p
(lane 1 in upper and lower panel). In the presence of increasing concentrations of curcumin (lanes
whereas levels of pro-PC7 (92 kDa) increased concomitantly.a similar way after transfection of these cells with a vector containing
the full-length α1-PDX cDNA while the control cells were transfected
with the empty vector.
2.12. Statistical analysis
Data are presented as mean ± SEM of three independent experi-
ments. Unpaired two-tailed Student's t-test was used for statistical
analysis. A p-value of b 0.05 was considered statistically signiﬁcant.
* represents p value b 0.05; ** represents p value b 0.01; *** represents
p value b 0.001. The graph artwork has been created using Microsoft
Ofﬁce Excel 2007 or OriginPro.8.SR0 (OriginLab Corporation; Northamp-
ton, MA 01060, USA).
3. Results
3.1. Effect of curcumin on hfurin573-mediated substrate processing in a
cell lysate based- and in an in vitro assay
Using the assay to monitor endogenous PC activity, as described
in the Materials and methods section, curcumin was compared with
three other polyphenols. These polyphenols, (−)EGC, biochanin A and
chrysin, served as negative controls and were chosen because earlier
work had shown that they do not inhibit the processing of neither
pro-IGF-1R nor pro-GPC3 in cells [33]. None of the four tested polyphe-
nols did affect endogenous PC activity in a signiﬁcant way except for
curcumin. These results as illustrated in Fig. 1A, reveals signiﬁcant inhi-
bition of endogenous PC activity upon treatment of CHO cells with
curcumin concentrations of 10 and 20 μM. Hardly any effect was ob-
served when CHO cells were treated with similar concentrations of
the other tested polyphenols, as illustrated in Fig. 1A.
In order to investigate whether curcumin is a direct inhibitor of
the PC furin, the effect of curcumin on the in vitro processing of a
genuine proprotein by hfurin273, i.e. uncleaved diphtheria toxin,
was performed. No inhibitory activity of curcumin (Fig. 1B) was ob-
served. In contrast to D9R, an established PC inhibitor (Fig. 1B lane 3),
curcumin did not inhibit the in vitro processing of uncleaved diphtheria
toxin by puriﬁed hfurin573 (Fig. 1B lanes 4–7). Altogether, the in vitro
experiments indicate that curcumin does not behave as a direct inhibi-
tor of furin.
In order to further validate the inhibitory effect of curcumin on the
endogenous cellular PC activity, CHO cells were transfected with DNAein convertases in CHO cells. In the various experiments, expression levels of actin are shown
re form furinwere studied in CHO cells byWestern blotting analysis, as described inMaterials
observed in CHO cell lysates aswell as shed furin (82 kDa) in themedium (left panel, lane 1).
ls of mature furin decreasedwhereas levels of pro-furin increased revealing the inhibition of
using rabbit polyclonal antibody hPro-furinAbwhich is speciﬁc for the pro-domain of human
easured in lysates (middle panel) or culture medium (right panel) of CHO cells treated with
ependent experiments, each performed in triplicate; (*** represents p value b 0.001 as com-
f the SERCA Ca2+ pump inhibitor thapsigargin (TG) (left panel in ﬁgure) was established in
indicated in the ﬁgure. Inhibitory effects of TG on endogenous PC activity were determined
entrations of TG, as indicated in the ﬁgure.). Data represent mean ± SEM of 3 independent
he untreated cells). C: Inhibition of pro-furin maturation by various concentrations of the
ntrations of added CPA are indicated in the ﬁgure. Inhibitory effects of CPA on endogenous
cells treated with various concentrations of CPA, as indicated in the ﬁgure. Data represent
0.001 as comparedwith the untreated cells). D: Effect of various concentrations of curcumin
upon transfection of a corresponding expression construct and studied by Western blotting
ponding to FLAG-tagged pro-PC1/3mut, a processingmutant of pro-PC1/3, is shown as a con-
e PC1/3 (87 kDa) could be observed inCHOcell lysates aswell as secretedmature PC1/3 in the
d corresponds to COOH-terminal truncated PC1/3 (66 kDa) (upper panel, lane 2). In the pres-
PC1/3decreasedwhereas levels of pro-PC1/3 increased concomitantly (upper panel, lanes 3–
r TG (lower panel) was established in similar experiments. E: Effect of various concentrations
HO cells upon transfection of a corresponding expression construct and studied byWestern
indicated in the ﬁgure. In the absence of curcumin (upper panel) or TG (lower panel), both
and lower panel). In the presence of increasing concentrations of curcumin (lanes 2–4, upper
ffect of various concentrations of curcumin (upper panel) or TG (lower panel) on zymogen
struct and studied byWestern blotting analysis, as described inMaterials andmethods. Con-
anel) or TG (lower panel), only mature PC7 (102 kDa) could be observed in CHO cell lysates
2–3, upper panel) or TG (lanes 2–4, lower panel), detectable levels of mature PC7 decreased
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pro-GPC4) and subsequently treated with increasing curcumin concen-
trations. Treatment of the transfected CHO cellswith curcumin revealed
that the ratio between the mature processed products and the corre-
sponding proproteins decreased at increasing curcumin concentrations
(Fig. 1C). (Bar graphs for Fig. 1C that represent the ratio intensity of the
bands of the proproteins as compared with their correspondingmature
forms are provided in the Supplementary Fig. 1). These results indicate
that curcumin impedes the processing properties of endogenously
expressed PC(s) in CHO cells.
3.2. Inhibition by curcumin of proprotein processing by ectopically
expressed PCs in furin-deﬁcient RPE.40 cells
The catalytic domains of proprotein convertases share high homology
[50]. For this reason variable degrees of redundancy are observed for the
processing of their substrates [12]. Since curcumin inhibited endogenous
PC-mediated processing of various proproteins, we examined whether
this inhibition could be attributed to inhibition of furin alone or whether
other PCs were also inhibited. Hence, we studied the processing of
pro-IGF-1R in co-expression experiments using RPE.40 cells, which lack
endogenous furin processing activity and fail to process pro-IGF-1R [51].
Three members of the mammalian PC family, including wild-type furin,
PC5/6 and PC7 were studied in co-expression experiments to assess
their pro-IGF-1R-processing activity (Fig. 2A). Consistent with a previous
report [51], furin and PC5/6, but not PC7, expression rescued pro-IGF-1R
processing as demonstrated by the detection of the α-chain of IGF-1R,
one of the pro-IGF-1R processing products. Strikingly, curcumin (5 and
10 μM)blocked the furin-mediated cleavage of pro-IGF-1R (Fig. 2A). Sim-
ilar results were obtainedwith PC5/6, while PC7 served as an additional
control. These data reveal that the inhibitory effect of curcumin on
proprotein processing results from targeting several members of the
subtilisin-like PC family.
Further experiments demonstrated that endogenously expressed PCs
in the furin-deﬁcient RPE.40 cells are able to process pro-GPC3 and pro-
GPC4 (Fig. 2B). Furthermore, curcumin (5 and 10 μM) blocked the pro-
cessing of pro-GPC3 as well as pro-GPC4 (Fig. 2B), suggesting that the
endoproteolytic processing activity of endogenously expressed PCs in
RPE.40 cells (which lack furin) are also affected by curcumin. (Bar graphs
for Fig. 2A and B that represent the ratio intensity of the bands of the
proproteins as compared with their corresponding mature forms are
provided in the Supplementary Fig. 2).
3.3. Inhibition by curcumin of intramolecular maturation of PC zymogens
Since the in vitro cleavage studies indicated that curcumin does not
directly inhibit furin-mediated processing activity, we examinedwhether
curcumin interfered with the production of active PCs. Therefore, the ef-
fect of curcumin on the synthesis of pro-furin zymogen and itsmaturation
into furin was studied in CHO cells ectopically expressing wild-type
human pro-furin. These experiments were performed with increasing
curcumin concentrations (Fig. 3A, ﬁrst panel).
In the absence of curcumin, pro-furin as well as mature furin, both in-
tracellularly and shed into the medium, could be detected using the
monoclonal antibody MON-148 directed against the substilisin-like cata-
lytic domain of furin (Fig. 3A, lanes 1–4), At increasing curcumin concen-
trations, the detected amount of pro-furin was increased whereas,
concomitantly, that of intracellular and shed furin was decreased. To ver-
ify and establish the identity of the pro-furin proteinmoiety, home-made
rabbit antiserumhpro-furinAbwas used. In Fig. 3A (lane5), only pro-furin
is detected but not mature furin. Thus curcumin suppresses the matura-
tion of pro-furin, which is mediated by an intramolecular autocatalytic
process in the endoplasmic reticulum (ER) [52]. Subsequent measuring
of PC activity in the FUR-transfected CHO cells treated with increasing
curcumin concentrations shows that the PC activity decreasessigniﬁcantly, both in the cell lysate (Fig. 3A, middle panel) as well as in
the medium (Fig 3A, right panel).
Since, with the exception of pro-PC2, PC maturation occurs in the ER
[52–55] which also functions as the main intracellular Ca2+ store [56]
and since an adequate ﬁlling state of the ER Ca2+ stores is a prerequisite
for proper protein processing [57], we hypothesized that curcumin could
attenuate furin processing by reducing the ER Ca2+ concentration.
Curcumin has been reported to inhibit the ER Ca2+-uptake activity of
SERCA [58]. We tested this hypothesis by assessing furin processing in
CHO cells exposed to two established but structurally unrelated SERCA in-
hibitors (TG and CPA). These act in an irreversible and a reversible man-
ner respectively, thereby causing a depletion of the ER Ca2+ stores. Both
SERCA inhibitors had a similar inhibitory effect on pro-furin maturation
as curcumin (Figs. 3B and C). Moreover, using the ﬂuorogenic peptide
substrate Pyr-RTKR-AMC, a similar reduction of PC activity both in the
cell lysates as in the corresponding media was observed (Figs. 3B and
C). In summary, the results reveal a dose-dependent increase in inhibitory
activity for all three compounds tested, both in the cell lysates and the cul-
ture media, which hints that the curcumin-mediated attenuation of
pro-furin maturation and associated decrease in PC activity is due to its
ability to inhibit the SERCA pumps.
Since most pro-PCs mature in the ER via a similar intramolecular
autocatalytic process we assessed whether or not maturation of
other pro-PCs are also affected by curcumin or TG. Therefore, CHO
cells were transfected with an expression construct encoding FLAG-
tagged pro-PC1/3 (Fig. 3D), an expression construct expressing pro-
PC2 (Fig 3E), or an expression construct encoding pro-PC7 (Fig. 3F). In
a control experiment, processing-impaired FLAG-tagged pro-PC1/
3mut was also studied (Fig. 3D, upper panel, lane 1). For PC1/3, PC2
and PC7, inhibition of maturation of their corresponding zymogens
was observed upon treatment with curcumin as well as TG. For
PC1/3 and PC7 as with furin this can be ascribed to the depletion of the
ER Ca2+ stores induced by both compounds. For PC2 an indirect effect
plays a role. Pro-PC2 does notmature in the ER but in the trans-Golgi net-
work [59]. The small neuroendocrine protein 7B2, present in all neural
and endocrine tissues, is known to be required for the maturation of cel-
lular pro-PC2 to themature form [59–61]. The PC-mediated processing of
the 27 kDa form of 7B2 results into its 21 kDa form. The latter form
facilitates maturation of pro-PC2 [59]. A 7B2 mutant construct in which
maturation of 27 kDa 7B2 to its 21-kDa form was blocked was unable
to facilitate maturation of pro-PC2 [59]. It is therefore well established
that maturation of pro-PC2 is attenuated by the reduction of the activity
of other PCs. It is obvious that curcumin and the other SERCA inhibitors
do not inﬂuence PCmaturation exclusively. All the Ca2+-dependent pro-
cesses in the ER will be inﬂuenced. It is therefore not surprising that
curcumin is a highly pleiotropicmoleculemodulating the biological activ-
ity of a number of signaling pathways [62].
Altogether, these results indicate that inhibition of zymogenmat-
uration constitutes a major contributing factor for the observed
PC-mediated processing inhibition induced by curcumin.3.4. Inhibitory effect of curcumin on Ca2+-uptake in the
endoplasmic reticulum
To determine whether curcumin inhibits ER Ca2+-uptake mecha-
nisms, we have assessed ATP-driven ER 45Ca2+ uptake in permeabilized
CHO cells in the presence of curcumin concentrations ranging from 0 to
20 μM. Importantly, these experiments were performed in the absence
of 45Ca2+ ﬂuxes over plasmalemmal and mitochondrial membranes
and in the absence of IP3R activity. Total 45Ca2+ uptake was corrected
for the TG-resistant part, which is due to 45Ca2+ uptake in non-ER stores
(as e.g. the Golgi apparatus) and/or to passive 45Ca2+ binding [63]. After
plasmamembrane permeabilization, cells were incubatedwith curcumin
during the 45Ca2+-loading phase and the ER 45Ca2+ contentwas assessed
after loading the ER Ca2+ stores to steady state. Fig. 4A shows a
1931J. Zhu et al. / Biochimica et Biophysica Acta 1833 (2013) 1924–1935representative experiment allowing assessment of the ER 45Ca2+
content in permeabilized CHO cells.
Curcumin, at concentrations as low as 5 μM, signiﬁcantly reduced the
ER Ca2+ content to about a third of its normal value. This could be due to
either inhibition of SERCA-driven active uptake of 45Ca2+ into the ER, by
an increase in the passive Ca2+ leakage out of the ER or to a combination
of both.We therefore testedwhether curcumin affects the passive 45Ca2+
efﬂux leak out of the ER (Fig. 4B). Importantly, curcumin (up to 30 μM)
did not affect the basal ER Ca2+-leak ratemeasured during unidirectional
45Ca2+ efﬂux conditions in the absence of SERCA activity. Taken together,
these data indicated that curcumin solely inhibits SERCA-mediated ERCa2+-uptake activity. A dose–response analysis (Fig. 4C) indicated that
curcumin inhibits SERCA in CHO cells at an IC50 of 4.5 μM.
In order to know whether a similar mechanism is playing a role in
colon cancer cell lines, a similar evaluation was performed for perme-
abilized cells of two different colon cancer cell lines, HT-29 and SW
480 (Fig. 4C). Similar results were obtained. A quantitative analysis of
the various cell lines, indicated that curcumin provokes in SW480
(IC50 of 3.8 μM) an about as strong inhibition as in CHO cells, while ER
Ca2+ uptake in HT-29 cells was slightly less potently inhibited (IC50 of
7.0 μM).
3.5. Impact of curcumin on IGF-1R-mediated signaling in colon
carcinoma cells
Our Ca2+-uptake experiments show that curcumin decreases
Ca2+-uptake in the ER in the CHO cells as well as in the two colon
cancer cell lines. This suggests that PC maturation might also be
inhibited in these cell lines. We studied the PC activity in the colon
cancer cell lines taking the processing of pro-IGF-1R as a model sub-
strate. The observation that curcumin indeed inhibits the processing
of pro-IGF-1R most likely has implications for the IGF-1R-signaling
pathway. IGF-1R is a ubiquitously expressed receptor-tyrosine ki-
nase. Binding of a growth factor such as IGF-1 to IGF-1R initiates intra-
cellular signaling. IGF-1 is one of the most potent natural activators of
the Akt signaling pathway, directs cell growth and proliferation, and
constitutes a potent inhibitor of programmed cell death. We therefore
studied the impact of curcumin on the maturation of the pro-IGF-1R
and on the phosphorylation of Akt, in cells of three different colon car-
cinoma cell lines, SW480, HT-29, and Caco-2. The cells were treated
with different concentrations of curcumin for 24 h and then stimulated
with IGF-1 (100 ng/ml) for 2 h in the presence of the different concen-
trations of curcumin (Fig. 5A). Stimulation of the cells with IGF-1 affect-
ed neither the processing of pro-IGF-1R nor the expression levels of Akt.
However, the levels of Akt phosphorylation (P-Akt) strongly increased
by IGF-1 stimulation of the cells, as expected.
In the presence of increasing curcumin concentrations, a signiﬁcant
decrease was observed in the processing of pro-IGF-1R, as measured by
the levels of the processing productα-chain. Nomajor effects of curcumin
on Akt-expression levels could be observed. However, the levels of P-Akt
decreased strongly and in a dose-dependent manner with increasing
curcumin concentrations in all three cell lines. These results indicate
that curcumin affects Akt phosphorylation indicative of inhibition of
IGF-1R-mediated signaling presumably due to reduced PC activity. To
substantiate this, the ﬂuorogenic peptide substrate Pyr-RTKR-AMC was
used to assay endogenous PC activity. Results revealed that the relative
PC activity in the curcumin-treated colon carcinoma cells decreased in a
dose-dependent manner, as expected (Fig. 5B). Moreover, real time
qRT-PCR experiments revealed that curcumin had no signiﬁcant effectFig. 4. Curcumin inhibits ATP-driven 45Ca2+ uptake in the ER of permeabilized CHO, HT-29
and SW480 cells. A: A representative experiment demonstrating the ER Ca2+ content
(in cpm) as a function of time (in minutes) in permeabilized CHO cells, in which the Ca2+
stores were actively loaded with 45Ca2+ to steady-state levels in the absence or presence
of curcumin (5 μMor 10 μM). The ER Ca2+ contentwas calculated as described in theMate-
rials and methods, meaning that only the TG-sensitive part of the 45Ca2+ uptake is plotted.
The graph shows that curcumin signiﬁcantly lowers the ER Ca2+ content in CHO cells. Data
represent mean ± SD of a typical experiment (out of 5) performed in duplicate. B: A repre-
sentative experimentdemonstrating thenormalizedER 45Ca2+ content (in%) as a functionof
time (inminutes) in permeabilized CHO cells. Storeswere loaded to steady statewith 45Ca2+
for 45 min and subsequently treatedwith the irreversible SERCA inhibitor TG. Unidirectional
release of 45Ca2+ from the intracellular stores is so induced. During this release phase,
curcumin (0–30 μM)or the Ca2+ ionophore A23187 (10 μM)was added during the timepe-
riod, indicated by the gray bar. A23187, but none of the curcumin concentrations, accelerated
the loss of 45Ca2+ from the intracellular Ca2+ stores. C: A dose–response curve representing
the normalized TG-sensitive ER 45Ca2+ content (expressed in %, compared with the control
condition) in CHO, HT-29 and SW480 cells as a function of the curcumin concentration.
The graph shows that curcumin inhibits ER 45Ca2+ uptake in all three cell lines butwith a dif-
ferent potency. The IC50 valueswere obtained usingHill-curve ﬁtting (OriginPro 8 SR0). Data
represent mean ± SEM of 3 to 5 independent experiments, each performed in duplicate.
Fig. 5. Effect of various concentrations of curcumin on IGF-1R andAkt signaling in the colon carcinoma cell lines SW480,HT-29, andCaco-2. A:Western blot analysis of pro-IGF-1R processing as
well as P-Akt andAkt expression in the three colon carcinoma cell lines stimulated by IGF-1 and treatedwith various concentrations of curcumin, as indicated in the various panels of theﬁgure.
Expressionof actin is shownasprotein loading control. B: Effect of various concentrations of curcumin, as indicated in theﬁgure, on the endogenousPCprocessing activity in the colon carcinoma
cell lines SW480, HT-29, and Caco-2. PC activity wasmeasured in vitro using the Pyr-RTKR-AMC ﬂuorogenic peptide substrate, as described inMaterials andmethods. Data represent mean ±
SEM of 3 independent experiments, each performed in duplicate; (*** represents p value b 0.001 as compared with the untreated cells).
1932 J. Zhu et al. / Biochimica et Biophysica Acta 1833 (2013) 1924–1935on the expression levels of the PC genes FUR, PACE4, PC5/6, and PC7nor on
that of the IGF-1R gene in the colon carcinoma cell lines studied, as illus-
trated for SW480 (Supplementary Fig. 3).
3.6. Effects of the SERCA Ca2+-pump inhibitors curcumin and TG on colon
carcinoma cell viability/proliferation and anchorage-independent colony
formation
The inhibitory effect of curcumin on pro-IGF-1Rprocessing and conse-
quently on IGF-1R-mediated signaling, a critical factor in tumorigenic pro-
cesses like tumor cell proliferation, implies that curcumin may affect
growth characteristics of tumor cells. One such feature is anchorage-
independent growth which can be monitored by the capacity of tumorFig. 6. Impact of curcumin and thapsigargin on cell viability/proliferation and anchorage-indep
represent the relative cell viability/proliferation for the three colon cancer cell lines in the presen
mean ± SEM of 3 independent experiments, each performed in triplicate. B: Impact ofα1-PDX
carcinoma cells. The impact of α1-PDX was assayed upon transfection of cells with a DNA co
methods. Colony counting results of treated cells are given relative to the results obtained
performed in triplicate; (*** represents p value b 0.001 as compared with the untreated cells)cells to grow and form colonies in soft agar. To test this possibility,
cells from three different colon carcinoma cell lines, SW480, HT-29,
and Caco-2 were studied. Cell viability/proliferation as a function of
the curcumin concentration was measured using the MTT assay.
The relative viability/proliferation of cells grown during 48 h in culture
medium containing increasing curcumin concentrations is shown in
Fig. 6A. Moderate curcumin concentrations (10 μM and below) did not
compromise cell viability/proliferation in any of the cell lines (Fig. 6A).
At higher concentrations, the effect of curcumin on cell viability/prolifer-
ation became apparent and also a differential effect between the three cell
lines, with SW480 as the most sensitive and HT-29 as the least sensitive
cancer cell line. Remarkably, these ﬁndings correlate very well with the
potency of curcumin to inhibit ER Ca2+ uptake in the different cell lines,endent cell growth using colon carcinoma cell lines SW480, HT-29, and Caco-2. A: Graphs
ce of various concentrations of curcumin (left panel) or of TG (right panel). Data represent
, curcumin, and TG on colony formation in soft agar using HT-29, SW480, and Caco-2 colon
nstruct expressing α1-PDX. Experiments were performed as described in Materials and
with untreated cells. Data represent mean ± SEM of 3 independent experiments, each
.
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7 μM) as the least sensitive cancer cell line. The difference in sensitivity
thus appears correlated to the effect on the ER Ca2+ uptake. A change in
ER Ca2+ uptake will have more effects than the inhibition of PCs alone.
As a consequence there need not be a direct correlation between viabili-
ty/proliferation on one side and furin inhibition on the other side. The
effect of increasing concentrations of TG on cell viability/proliferation
is somewhat different from that of curcumin (Fig. 6A). Although the
viability/proliferation MTT assay appears to be highly correlated with
for example clonogenic assays [64], anchorage-independent growth re-
mains a more accurate test for transformation [65]. It is widely used as
an assay for detecting suppression of the malignant phenotype of cells.
Based on the cell viability/proliferation results, a curcumin concentra-
tion of 10 μM was chosen to study the effect of the two compounds
on anchorage-independent growth of the colon carcinoma cells. At
this concentration cell viability/proliferation was not signiﬁcantly dif-
ferent for the three cell lines. For TG a concentration of 500 nMwas cho-
sen. In the absence of curcumin or TG, cells of each of the three colon
carcinoma cell lines readily formed multiple large colonies, over a period
of threeweeks. In the presence of 10 μMcurcumin or 500 nM TG no such
cell colonies were formed (results not shown). The number of colonies
formed was signiﬁcantly inﬂuenced by incubation with either curcumin
or TG (Fig. 6B). Transfection of cells with the DNA-construct encoding
for the protein-based inhibitor 1-antitrypsin Portland (α1-PDX) known
to inhibit proprotein convertases also reduced the number of colonies
(Fig. 6B). The effect α1-PDX is less pronounced than that of curcumin or
TG. This is not surprising since curcumin and TG have effects on all cells
while it cannot be expected that transfection with α1-PDX is 100%
efﬁcient (usually, dependent on the cell type, transfection efﬁciency is be-
tween 20 and 80%).
Curcumin will not speciﬁcally inhibit PCs, but it will inﬂuence the ac-
tivity of other calcium-dependent processes in the ER. However, selective
inhibition of proprotein convertases with α1-PDX in HT-29 cells was
demonstrated to be sufﬁcient to reduce anchorage-independent growth
[19] and the ability to form liver metastases [51] by these cells. These re-
sults together with ours, which also includes the use of HT-29 cells, indi-
cate that the capacity of curcumin to inhibit PC zymogen maturation and
consequently PC activity is sufﬁcient to effectively block a hallmark fea-
ture of tumor cells, i.e. anchorage-independent cell growth.
4. Discussion
Although PC inhibitory activities have been attributed to polyphenols
[66] these activities were shown to be limited to in vitro inhibition of the
processing of a ﬂuorogenic peptide substrate only and related to binding
of the auto-oxidation products of the polyphenols to the enzyme protein
[33]. The results of studies presented here with curcumin demonstrate
that treatment of transfected CHO cellswith this polyphenol leads to inhi-
bition of the processing of pro-IGF-1R, pro-GPC3 and pro-GPC4 in a
dose-dependent manner. Curcumin did not inhibit the processing of
pro-diphtheria toxin in vitro. These observations strongly point to-
wards an indirect mechanism of inhibition by curcumin of endoge-
nous PC activity in the CHO cells. Similar inhibitory activities by
curcumin were observed in experiments with the PCs furin and PC5/6,
ectopically expressed in furin-deﬁcient RPE.40 cells via transfection of
suitable expression constructs. Together, these results indicate that the in-
hibitory activity of curcumin is not speciﬁc for only furin and PC5/6 but
most likely affects all PCs. If so, this would imply that curcumin affects a
common property required for proprotein processing activity of the
members of the PC family.
Curcumin is a potent inhibitor of the SERCA Ca2+ pumps [57], which
are involved in the adequate ﬁlling of the ER Ca2+ stores and the con-
trolled maintenance of the submicromolar levels of Ca2+ within the cell
cytoplasm. Curcumin apparently exerts its inhibitory activity towards
the SERCA Ca2+ pumps by interfering with ATP binding and so inhibiting
Ca2+-dependent ATPase activity [58]. In this context, it is of interest tonote that curcumin has been found to affect the enzymatic activity of
a number of critical enzymes and processes which are known to be regu-
lated by Ca2+ [67–70]. The observed inhibitory effect of curcumin on
PC-zymogen maturation likely is due to the fact that curcumin inhibits
the SERCA Ca2+ pumps and that PCs are produced in the ER via zymogen
maturation, presumably involving Ca2+-dependentmaturation steps and
requiring an adequate ER Ca2+-ﬁlling state. This concept is underpinned
by the fact that the two structurally unrelated SERCA Ca2+ pump inhibi-
tors TG and CPA exerted a similar effect on PC zymogenmaturation. Ca2+
loading in the ER compartment is indeed affected in a concentration-
dependent manner by curcumin, as shown in the unidirectional ER
Ca2+-uptake and -leak assays.
All these results support the concept that curcumin-induced inhibition
of the SERCA Ca2+ pumps affects PC-mediated proprotein processing by
attenuating maturation of PC zymogens. The importance of proper intra-
cellular Ca2+ homeostasis for the processing of PC substrates is highlight-
ed by a recent study on the Golgi Ca2+ pump, the Secretory Pathway
Ca2+ ATPase 1 (SPCA1) [71]. In this study, siRNA-mediated silencing of
the SPCA1 gene in a basal-like breast cancer cell line had a profound effect
on the processing of pro-IGF-1R. Whereas SPCA1 is localized to the Golgi,
curcumin exerts its effect on Ca2+ signaling further upstream in the se-
cretory pathway, i.e. at the level of the ER.
In the context of our study, we also investigated the effect of curcumin
on tumorigenesis-linked molecular signaling in colon carcinoma cells
using three distinct colon carcinoma cell lines, SW480, HT-29, and
Caco-2.We focusedon IGF-1R- andAkt-mediated signaling, both critically
involved in tumorigenic processes. Impaired processing of pro-IGF-1R in
the presence of curcumin critically hurts this signaling pathway in all
three cell lines. Also the dose-dependent inhibition of Akt phosphoryla-
tion renders a critical molecular signaling component ineffective. These
observations could be indicative for a mechanism according to which, at
least in part, the anticancer capability of curcumin could be explained.
The anticancer effect was further substantiated by results from studies
in which anchorage-independent growth, one of the hallmarks of cancer
cells, was lost upon curcumin treatment in each of the three different
colon carcinoma cell lines. The results of our studies are in line with re-
sults of previous reports about the potent anticancer activity of curcumin
not only in vitro but also in vivo and on a variety of cancer types, including
leukemia, breast cancer, prostate cancer, and pancreatic cancer [72–74]. It
should be kept in mind that the PC inhibitory activity of curcumin does
not only have an impact on the processing of pro-IGF-1R demonstrated
in the present study. Curcumin's inhibitory effect on PC activity will also
have an impact on anumber of downstream targets in signalingpathways
that contain a component that is activated by PC-processing. Our results
imply that the reported anti-cancer effects of curcumin will depend on
the collective effects on all these pathways rather than the inﬂuence of
curcumin on the IGF-1R alone.
Curcumin is a natural component of turmeric and is used world-wide
at a large scale as daily food component. Furthermore, it has been used in
clinical trials in volunteers, using daily doses of up to 8 gwith only limited
toxicity [75]. These ﬁndings and the results of the present study, should
not lead to therapeutic usewithout adequatemedical supervision. Earlier
work has shown that there might be safety issues for patients with
reduced immune competence [76,77]. As an example, in patients
with monoclonal gammopathies the immune system is sometimes
compromised and caution in such patients is therefore warranted
[78]. With regard to the effects of curcumin as a PC inhibitor, it must be
kept in mind that its poor bioavailability [79] will require high doses of
curcumin for signiﬁcant PC inhibition in most organs and tissues. Since
curcumin inhibits several PCs, this increases the risk for side effects [80].
The highest concentrations of curcumin were found in the stomach and
the intestine [79]. As a consequence the future of curcumin as a PC inhib-
itor ismost promising in these tissues. In our studies, the focuswas there-
fore on colon carcinoma for which, as mentioned in the introduction, the
IGF-1R is being considered as a promising therapeutic target. The lack of
speciﬁcity of curcumin as a PC inhibitor is therefore at least partially
1934 J. Zhu et al. / Biochimica et Biophysica Acta 1833 (2013) 1924–1935compensated by its poor bioavailability inmost tissues, except the gastro-
intestinal tract.
In conclusion, our studies have clearly established a link between the
anticancer capabilities of a polyphenol, i.e. curcumin, and the critically im-
portant family of PCs in the context of tumor cells, i.e. colon carcinoma
cells. This link constitutes an indirect inhibitory effect of curcumin on
the maturation of the zymogens of the Ca2+-dependent PCs, which
is caused by the inhibition by curcumin of the SERCA Ca2+ pumps.
Curcumin's inhibitory effect on PC activity explains its impact on a num-
ber of downstream targets in different signaling pathways.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2013.04.002.Acknowledgments
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